About shuttle pharmaceuticals holdings inc - SHPH
Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.
SHPH At a Glance
Shuttle Pharmaceuticals Holdings, Inc.
401 Professional Drive
Gaithersburg, Maryland 20879
| Phone | 1-240-430-4212 | Revenue | 0.00 | |
| Industry | Pharmaceuticals: Major | Net Income | -11,721,669.00 | |
| Sector | Health Technology | Employees | 2 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
SHPH Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 1.616 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -0.266 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.082 |
SHPH Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -5,860,834.50 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
SHPH Liquidity
| Current Ratio | 0.063 |
| Quick Ratio | 0.063 |
| Cash Ratio | 0.042 |
SHPH Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -180.58 |
| Return on Equity | -791.043 |
| Return on Total Capital | -471.395 |
| Return on Invested Capital | -698.417 |
SHPH Capital Structure
| Total Debt to Total Equity | 10.297 |
| Total Debt to Total Capital | 9.336 |
| Total Debt to Total Assets | 2.216 |
| Long-Term Debt to Equity | 6.873 |
| Long-Term Debt to Total Capital | 6.232 |